El descubrimiento de los genes BRCA1 y BRCA2 ha llevado a la introducción de pruebas genéticas cada vez más sofisticadas para medir el riesgo de cáncer de mama de origen hereditario, entre otras cosas.
Adriana A Rodríguez, Steven A Narod
core
The Performance of <i>In Silico</i> Prediction Tools for Variant Curation in a Panel of Cancer Genes. [PDF]
Nelson N +5 more
europepmc +1 more source
Exon-Specific Targeted Analysis of <i>BRCA1</i> and <i>BRCA2</i> Mutations in Bangladeshi Breast Cancer Patients. [PDF]
Dutta S +4 more
europepmc +1 more source
BRCA1 deficiency induces NFκB-dependent type-I interferon signaling in fallopian tube epithelial cells. [PDF]
Madaan V, Kollara A, Spaner D, Brown TJ.
europepmc +1 more source
Higher Levels of <i>BRCA1</i> Gene Methylation in Sporadic Breast Cancer Patients with a Lower Incidence of Recurrence. [PDF]
Agnes G +5 more
europepmc +1 more source
Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women. [PDF]
Beasley HK +11 more
europepmc +1 more source
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study. [PDF]
Kayali M +20 more
europepmc +1 more source
Breast cancer risk genes affecting individual radiosensitivity. [PDF]
Vogel RKG +10 more
europepmc +1 more source
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer. [PDF]
Kano M +17 more
europepmc +1 more source

